Компоненты питания и коронарная болезнь сердца. Антиоксиданты в питании. Профилактика через питание, страница 8

43.  Morris CD, Carson S (2003) Clinical guidelines: routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 139:56—70 (Примечание автора: обобщение работ о добавле нии витаминов в питание)

44.  Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy RP, Siscovick DS (2003) Cardiac benefits offish consumption may de pend on the type offish meal consumed: the cardiovascular health study. Circulation 107:1372-1377

45.  Mozaffarian D, Psaty BM, Rimm EB et al. (2004) Fish Intake and Risk of Incident Atrial Fibrillation. Circulation 110:368—373

46.  Oomen CM, Ocke MC, Feskens EJM, Van Erp-Baart M-AJ, Kok FJ, Kromhout D (2001) Association between trans fatty acid inta ke and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357:746—751

47.  Parikh P, McDaniel MC, Ashen MD et al. (2005) Diets and cardiovascular disease an evidence-based assessment. J Am Coll Cardi- 0145:1379-1387

48.  Pietinen P, Rimm EB, Korhonen P et al (1996) Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the alpha-tocopherol, beta-carotene cancer prevention study. Circulation 94:2720-2727

49.  Robertson RM, Smaha L (2001) Can a Mediterranean-stylediet reduce heart disease? Circulation 103:1821-1822


50.  Ros E, Nunez I, Perez-Heras A et al (2004) A walnut diet improves endotheiial function in hypercholesterolemic subjects a randomi zed crossover trial. Circulation 109:1609—1614

51.  Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC (2000) Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 343:16-22

52.  Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD (1999) Purple grape juice improves endotheiial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050—1055

53.  Thies F, Garry JMC, Yaqoob P et al (2003) Association of omega-3 polyunsaturated fatty acids with stability of atherosclerotic plaqu es: a randomised controlled trial. Lancet 361:477—485

54.  Tribble DL for the Nutrition Committee (1999) Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene — a statement for healthcare professionals from the American Heart Association. Circulation 99:591—595

55.  von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H (1999) The effect of dietary Omega-3 fatty acids on coronary atherosc lerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 130:554-562

56.  Wahrburg U, Martin H, Sandkamp M et al (1992) Comparative effect of recommended lipid lowering diet vs. a diet rich in monounsa- turated fatty acids on serum lipid profiles in healthy young adults. Am J Clin Nut 56:678-683

57.  Warshafsky S, Kamer RS, Sivak SL (1993) Effect of garlic ontotal   serum   cholesterol   —   a   meta-analysis.   Ann   Intern   Med 119:599-605

58.  Weber PC (1989) Epidemiologische und biochemische Studien uber Omega-3 Fettsauren in der Pravention der Atherosklerose. Inter nist 30:283-290

59.  Woolett LA, Spadey DK, Dietschy JM (1989) Mechanisms bywhich triacylated triglycerols elevate the plasma low density lipoprote- in cholesterol concentration in hamsters: differential effects of fatty acid chain length. J Clin Invest 84:119—128.